Funding Opportunities

Grants for melanoma and skin cancer clinical research

Melanoma and Skin Cancer Trials conducts investigator-initiated clinical trials and related research to improve how doctors prevent, diagnose and treat melanoma and skin cancer.

We have built an impressive reputation for delivering multicentre trials that improve melanoma and skin cancer outcomes across the world. Since 1999, we have delivered 29 clinical trials involving over 7,500 participants.

Melanoma and Skin Cancer Trials facilitates the development of competitive investigator-initiated proposals through our concept development pathway. For more information on how we can help you develop a research proposal and secure funding, contact us.

NHMRC Partnership Projects 2025 – GO7440

Open Date

8 January 2025

Closing Date

26 November 2025

Grant amount

$1,500,000 AUD (Total amount: $31,600,000 AUD)

Application website

NHMRC’s online granting system (Sapphire).

About

Partnership Projects will support collaborations, within the Australian context, that translate research evidence into health policy and health practice, to improve health services and processes.

The objectives of the Partnership Project scheme are to:

meet the need for more effective integration of research evidence into health policy and service delivery
create partnerships among policy makers, managers, service providers and researchers
provide support to answer often complex and difficult questions that policy makers, managers and service providers face when making decisions and implementing policies that affect Australians health and health care
be highly responsive to the priorities of government, the community and health professionals
enable applicants to apply for funding at any time during the year to allow researchers and Partner Organisations to develop timely collaborations.

MRFF – 2025 Research Data Infrastructure Grant Opportunity - GO7714

Open Date

14 August 2025

Closing Date

11 December 2025

Grant amount

$2,500,000 AUD (Total amount: $20,000,000 AUD)

Application website

MRFF 2025 RDI

About

This grant opportunity is part of the Medical Research Future Fund and the Research Data Infrastructure Initiative. It looks to fund the creation or extension of national research data infrastructure to support world-class health and medical research in Australia.

The objective of this grant opportunity is to provide grants of financial assistance to support Australian medical research and medical innovation projects that use novel methods to harness multiple existing data infrastructure types in developing and implementing new approaches for addressing an unmet medical need.

Research proposals should incorporate:

new linkage and/or use of data from multiple (at least two) existing research data infrastructure sources of different types (e.g. administrative and biobank data, registry and biobank data, wearables and use artificial intelligence); and/or
novel methodologies and approaches that leverage and enhance existing linked research data infrastructure of at least two different types (e.g. administrative and biobank data, registry and biobank data, wearables and use artificial intelligence); and
a clear outline of how the proposed project will produce knowledge and outcomes that address an area of unmet medical need.

MRFF – Genomics Health Futures Mission – 2025 Genomics Health Futures Grant Opportunity – GO7833

Open Date

13 August 2025

Closing Date

4 February 2026

Grant amount

$10,000,000 AUD (Total amount: $48,800,000 AUD)

Application website

NHMRC’s online granting system (Sapphire).

About

The Medical Research Future Fund (MRFF) – Genomics Health Futures Mission (GHFM) – 2025 Genomics Health Futures Grant Opportunity will provide grants of financial assistance to support medical research and medical innovation projects that:

Stream 1 (Targeted Call for Research): develop and implement pharmacogenomic approaches to identify new medicines and enhance medication efficacy.

Funding under Stream 1 is available as follows:

Topic A: Cancer therapies

Topic B: Antimicrobials

Topic C: Medicines for other infectious or chronic diseases

Stream 2 (Targeted Call for Research): conduct genomics research to optimise the diagnosis, treatment, monitoring and prevention of high-priority and high-burden diseases among Aboriginal and/or Torres Strait Islander peoples.

The intended outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by:

– Stream 1: improving precision medicine to enhance medication efficacy and safety

– Stream 2: targeting genomic solutions to diseases prevalent among Aboriginal and/or Torres Strait Islander peoples

Applicants to this grant opportunity must propose to conduct research that delivers against the above objectives and those of the Mission as described in the Roadmap and Implementation Plan. Applicants are encouraged to propose novel and/or innovative research and describe how the outcomes of the research will be translated into health benefits for Australians.

This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health, Disability and Ageing.

Further information on the Medical Research Future Fund is available from the Department of Health, Disability and Ageing’s website

A list of Eligible Organisations can be found on the NHMRC List of MRFF Eligible Organisations webpage.

MRFF – Clinical Trials Activity Initiative – 2025 International Clinical Trial Collaborations Grant Opportunity – GO7555

Open Date

20 February 2025

Closing Date

4 February 2026

Grant amount

$3,000,000 AUD (Total amount: $13,000,000 AUD)

Application website

MRFF – Clinical Trials Activity Initiative – 2025 International Clinical Trial Collaborations Grant Opportunity

About

The Medical Research Future Fund (MRFF) Clinical Trials Activity Initiative (the Initiative) aims to increase clinical trial activity in Australia in order to improve the evidence base supporting clinical care and to help patients access trials relevant to their health circumstances, and enable researchers to bring international trials to Australian patients.

The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that:

Promote Australian involvement in international collaborative investigator-initiated clinical trials research through the establishment and co-ordination of clinical trial site/s in Australia.
Provide high-quality evidence of the effectiveness of novel health treatments, drugs or devices in ‘usual care’ settings, which will support a decision on whether to deliver the intervention in an Australian setting.

The intended outcome of the research is to improve the health and wellbeing of Australians by investing in new clinical trials that support increased access to high-quality, evidence-based and effective health care.

Applications must propose a clinical trial in Australia in collaboration with international counterparts. The clinical trial should not have commenced recruitment at the Australian trial site/s.

This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health and Aged Care.

Further information on the Medical Research Future Fund is available from the Department of Health and Aged Care’s website.

A list of Eligible Organisations can be found on the NHMRC List of MRFF Eligible Organisations webpage.

Other Instructions:
Minimum Data closes at 5:00pm (ACT Local Time) on:

Round 1: 2 July 2025

Round 2: 10 December 2025

Questions should be submitted no later than 1:00pm (ACT Local Time) on:

Round 1: 23 July 2025

Round 2: 28 January 2026

MRFF 2022 Frontier Health and Medical Research Grant Opportunity – GO5855

Open Date

13 February 2023

Closing Date

31 March 2026

Grant amount

$25,000,000 AUD (Total amount: $400,000,000 AUD)

Application website

MRFF 2022 Frontier Health and Medical Research Grant Opportunity

About

This grant opportunity offers funding to support medical research and medical innovation programs of research that deliver a ‘moonshot’ by creating a treatment for a currently serious and incurable health condition, through a series of linked projects. The program of research can propose to develop novel health technologies and/or re-purpose existing health technologies in a novel way.

MRFF – CTA Initiative - 2025 Clinical Trials Activity Grant Opportunity - GO7923

Open Date

24 September 2025

Closing Date

1 April 2026

Grant amount

$5,000,000 AUD (Total amount: $61,000,000 AUD)

Application website

NHMRC’s online granting system (Sapphire).

About

The Medical Research Future Fund (MRFF) Clinical Trials Activity Initiative aims to:

improve the evidence base supporting clinical care
help patients access trials relevant to their health circumstances
enable researchers to bring international trials to Australian patients.

The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that:

Stream 1 (Incubator): conduct a pilot study to assess the feasibility of a new clinical trial for one or more treatments and/or management strategies for a rare cancer, rare disease and/or unmet need.
Stream 2 (Targeted Call for Research): conduct a clinical trial of one or more treatments and/or management-based interventions for rare cancers, rare diseases and/or unmet need.
Stream 3 (Targeted Call for Research): conduct a clinical trial that supports the delivery of effective and high value care by targeting evidence gaps of value to health technology assessment processes in Australia.
Stream 4 (Targeted Call for Research): conduct a prevention clinical trial aimed at reducing the risk, onset or progression of disease through early intervention strategies.

Applicants to this grant opportunity must propose research that addresses one of the four Streams of research.

This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health, Disability and Ageing.

Further information on the Medical Research Future Fund is available fromthe Department of Health, Disability and Ageing’s website.

A list of Eligible Organisations can be found on the NHMRC List of MRFF Eligible Organisations webpage.

Other Instructions:

Minimum Data closes at 5:00pm (ACT Local Time) on 4 March 2026. Questions should be submitted no later than 1:00pm (ACT Local Time) on 25 March 2026.

International Grant Opportunities:

NIH Exploratory Grants in Cancer Control – Funding Opportunity Number: PA-25-253

Open Date

16 January 2025

Closing Date

16 October 2025

Grant amount

The total funds available is up to: $275,000 USD

Application website

Exploratory Grants in Cancer Control

About

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) encourages the submission of exploratory/developmental research grant (R21) applications that focus on different aspects of cancer control by modifying behavior, screening, and understanding etiologic factors contributing to the development of cancer, and developing ways to control cancer.

The overarching goal is to provide support to promote the early and conceptual stages of research efforts on novel scientific ideas that have the potential to substantially advance population-based cancer research, such as the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research (e.g. epidemiologic, biomedical, behavioural, health care delivery or clinical).